Expression of Collagen XIII in Tissues of the Thyroid and Orbit With Relevance to Thyroid-Associated Ophthalmopathy
Investigative Opthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.4.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, 2024. Verfasst von Oula Norman und 10 weiteren Autor:innen. Beteiligte Einrichtung: ECM-Hypoxia Research Unit, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland. Hauptthemen laut MEDLINE: Graves Ophthalmopathy, Graves Disease, Goiter. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Antibodies against collagen XIII have previously been identified in patients with active thyroid-associated ophthalmopathy (TAO). Although collagen XIII expression has been described in extraocular muscles and orbital fat, its detailed localization in extraocular and thyroid tissues and the connection to autoimmunity for collagen XIII remain unclear. Our objective was to map the potential targets for these antibodies in the tissues of the orbit and thyroid.
Methods
We evaluated the expression of collagen XIII in human patient and mouse orbital and thyroid tissues with immunostainings and RT-qPCR using Col13a1-/- mice as negative controls. COL13A1 expression in Graves' disease and goiter thyroid samples was compared with TGF-β1 and TNF, and these were also studied in human thyroid epithelial cells and fibroblasts.
Results
Collagen XIII expression was found in the neuromuscular and myotendinous junctions of extraocular muscles, blood vessels of orbital connective tissue and fat and the thyroid, and in the thyroid epithelium. Thyroid expression was also seen in germinal centers in Graves' disease and in neoplastic epithelium. The expression of COL13A1 in goiter samples correlated with levels of TGF-B1. Upregulation of COL13A1 was reproduced in thyroid epithelial cells treated with TGF-β1.
Conclusions
We mapped the expression of collagen XIII to various locations in the orbit, demonstrated its expression in the pathologies of the Graves' disease thyroid and confirmed the relationship between collagen XIII and TGF-β1. Altogether, these data add to our understanding of the targets of anti-collagen XIII autoantibodies in TAO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- ECM-Hypoxia Research Unit, Faculty of Biochemistry and Molecular Medicine, University of Oulu, Oulu, Finland.
- Department of General Surgery, Oulu University Hospital, and Medical Research Centre, University of Oulu, and Oulu University Hospital, Oulu, Finland.
- Department of Ophthalmology, Oulu University Hospital, and Research Unit of Clinical Medicine, Medical Research Centre, University of Oulu, and Oulu University Hospital, Oulu, Finland.
- Cancer and Translational Medicine Research Unit, Medical Research Centre Oulu, University of Oulu, and Oulu University Hospital, Oulu, Finland.
Zitieren
APA
Norman, O., Vornanen, T., Franssila, H., Liinamaa, J., Karvonen, E., Kotkavaara, T., Pohjanen, V. M., Ylikärppä, R., Pihlajaniemi, T., Hurskainen, M., & Heikkinen, A. (2024). Expression of Collagen XIII in Tissues of the Thyroid and Orbit With Relevance to Thyroid-Associated Ophthalmopathy. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.65.4.6
Vancouver
Norman O, Vornanen T, Franssila H, Liinamaa J, Karvonen E, Kotkavaara T, et al. Expression of Collagen XIII in Tissues of the Thyroid and Orbit With Relevance to Thyroid-Associated Ophthalmopathy. Investigative Opthalmology & Visual Science. 2024. doi:10.1167/iovs.65.4.6
BibTeX
@article{Norman2024,
author = {Norman, Oula and Vornanen, Tuuli and Franssila, Hanna and Liinamaa, Johanna and Karvonen, Elina and Kotkavaara, Tommi and Pohjanen, Vesa-Matti and Ylikärppä, Ritva and Pihlajaniemi, Taina and Hurskainen, Merja and Heikkinen, Anne},
title = {Expression of Collagen XIII in Tissues of the Thyroid and Orbit With Relevance to Thyroid-Associated Ophthalmopathy},
journal = {Investigative Opthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.4.6}
}
EUVIMED